ACAD vs CMS · P/E 15, rev $957.8M vs P/E 20, $22.42B cap
ACADIA Pharmaceuticals Inc (ACAD) versus CMS Energy Corporation (CMS) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
CMS Energy Corporation (CMS) is a utilities - regulated electric company listed on US.
Latest reported ACAD revenue for 2024-12-31 was $957.8M. Net income was $226.5M. Revenue was up 314.6% from 2023-12-31 to 2024-12-31. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
CMS does not have a complete income-statement cache yet.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. CMS currently screens at market cap $22.42B and trailing P/E 20.1.
Not investment advice. Open the ACAD and CMS stock pages for the full models.
Not investment advice.